Real-time Neurofeedback Training of the Medial Prefrontal Cortex Based on Positive Episodic Future Thinking
Launched by UNIVERSITY OF ELECTRONIC SCIENCE AND TECHNOLOGY OF CHINA · Jan 15, 2025
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a technique called neurofeedback, which uses real-time brain imaging to help participants learn how to control their brain activity. Specifically, the trial focuses on a part of the brain called the medial prefrontal cortex (mPFC) and aims to see if training this area can help people feel more positive and hopeful about the future. Participants will either receive the actual neurofeedback training or a sham (inactive) version to compare results.
To join the study, participants should be healthy adults aged between 65 and 74 years, with no history of brain injuries or mental health issues. They should not be taking medications or using drugs that affect the brain. Those who participate will undergo MRI scans while they engage in activities designed to help them learn to improve their brain function. This trial is currently recruiting, and it provides a unique opportunity to explore how we can enhance positive thinking through brain training.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Healthy subjects without any past or present psychiatric or neurological disorders
- Exclusion Criteria:
- • History of brain injury
- • Psychiatric or Neurological Disorder
- • Contraindications for MRI
- • Regular use of psychotropic substances (medication, drugs)
About University Of Electronic Science And Technology Of China
The University of Electronic Science and Technology of China (UESTC) is a leading institution renowned for its research and innovation in electronics and information technology. Established with a commitment to advancing scientific knowledge and fostering technological development, UESTC plays a pivotal role in clinical research, particularly in the integration of electronic technologies with healthcare. The university's robust academic framework, combined with its focus on interdisciplinary collaboration, enables the design and execution of clinical trials that aim to enhance medical practices and improve patient outcomes. Through its dedication to excellence and innovation, UESTC contributes significantly to the advancement of healthcare solutions on both a national and global scale.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chengdu, Sichuan, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported